KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for AbbVie (ABBV) over the last 14 years, with Q4 2024 value amounting to $7.1 billion.

  • AbbVie's Accumulated Depreciation & Amortization rose 732.77% to $7.1 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $7.1 billion, marking a year-over-year increase of 732.77%. This contributed to the annual value of $7.1 billion for FY2024, which is 732.77% up from last year.
  • AbbVie's Accumulated Depreciation & Amortization amounted to $7.1 billion in Q4 2024, which was up 732.77% from $6.6 billion recorded in Q4 2023.
  • In the past 5 years, AbbVie's Accumulated Depreciation & Amortization ranged from a high of $7.1 billion in Q4 2024 and a low of $5.6 billion during Q4 2020
  • For the 5-year period, AbbVie's Accumulated Depreciation & Amortization averaged around $6.2 billion, with its median value being $6.1 billion (2022).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first increased by 10.69% in 2021, then surged by 983.31% in 2023.
  • AbbVie's Accumulated Depreciation & Amortization (Quarter) stood at $5.6 billion in 2020, then rose by 0.11% to $5.6 billion in 2021, then rose by 7.73% to $6.1 billion in 2022, then grew by 9.83% to $6.6 billion in 2023, then rose by 7.33% to $7.1 billion in 2024.
  • Its Accumulated Depreciation & Amortization was $7.1 billion in Q4 2024, compared to $6.6 billion in Q4 2023 and $6.1 billion in Q4 2022.